Physician profile
Morgan Smither
NPI 1740842715
$2,538.68
in general payments reported to CMS, 2019-2025
17 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $550 · 2022: $362 · 2023: $278 · 2024: $795 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.90 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $526.68 | 2021-2025 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $438.63 | 2022-2025 | Caplyta |
| Abbvie INC. | $419.53 | 2021-2024 | |
| Lundbeck LLC | $237.87 | 2021-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $210.36 | 2021-2025 | Rexulti, Abilify Maintena |
| Sunovion Pharmaceuticals INC. | $155.49 | 2021-2022 | |
| Tris Pharma INC | $115.55 | 2023 | Dyanavel Xr, Quillichew Er, Quillivant |
| Corium, LLC | $91.22 | 2024-2025 | Azstarys |
| Janssen Pharmaceuticals, INC | $82.31 | 2022-2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $56.16 | 2025 | Austedo Xr |
| Neos Therapeutics, LP | $52.99 | 2022-2025 | Adzenys Xr-Odt |
| Noven Therapeutics, LLC | $42.63 | 2024-2025 | Xelstrym |
| Vanda Pharmaceuticals INC. | $36.60 | 2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $26.74 | 2024 | Auvelity |
| Jazz Pharmaceuticals INC. | $16.44 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $16.20 | 2021 | |
| Neurocrine Biosciences, INC. | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Smither listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.